Sex differences in nonobstructive coronary artery disease: Recent insights and substantial knowledge gaps

Trends in Cardiovascular Medicine

Volumn 27, Issue 3, 2017, Pages 173-179

  Paul, Tracy K ^a   Sivanesan, Kaartiga ^a   Schulman Marcus, Joshua ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b ALBANY MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Sex differences

Indexed keywords

ANGINA PECTORIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; EPICARDIUM; FEMALE; HUMAN; MALE; MICROVASCULAR ISCHEMIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYMPTOMATOLOGY; AGED; HEALTH CARE DISPARITY; HEALTH DISPARITY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

AGED; CORONARY ARTERY DISEASE; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84995467130     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2016.08.002     Document Type: Review

References (40)

1. [1] Shaw, L.J., Bugiardini, R., Merz, C.N., Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 54 (2009), 1561–1575.
2. [2] Garcia, M., Mulvagh, S.L., Bairey Merz, C.N., Buring, J.E., Manson, J.E., Cardiovascular disease in women: clinical perspectives. Circ Res 118 (2016), 1273–1293.
3. [3] Han, S.H., Bae, J.H., Holmes, D.R. Jr., Lennon, R.J., Eeckhout, E., Barsness, G.W., et al. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J 29 (2008), 1359–1369.
4. [4] Lansky, A.J., Ng, V.G., Maehara, A., Weisz, G., Lerman, A., Mintz, G.S., et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging 5:Suppl. 3 (2012), S62–S72.
5. [5] Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
6. [6] Pepine, C.J., Ferdinand, K.C., Shaw, L.J., Light-McGroary, K.A., Shah, R.U., Gulati, M., et al. Emergence of nonobstructive coronary artery disease: a woman׳s problem and need for change in definition on angiography. J Am Coll Cardiol 66 (2015), 1918–1933.
7. [7] Maddox, T.M., Stanislawski, M.A., Gunwald, G.K., Bradley, S.M., Ho, P.M., Tsai, T.T., et al. Nonobstructive coronary artery disease and risk of myocardial infarction. J Am Med Assoc 312 (2014), 1754–1763.
8. [8] Maddox, T.M., Ho, P.M., Roe, M., Dai, D., Tsai, T.T., Rumsfeld, J.S., Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes 3 (2010), 632–641.
9. [9] Leipsic, J., Taylor, C.M., Gransar, H., Shaw, L.J., Ahmadi, A., Thompson, A., et al. Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology 273 (2014), 393–400.
10. [10] Schulman-Marcus, J., ó Hartaigh, B., Gransar, H., Lin, F., Valenti, V., Cho, I., et al. Sex-specific associations between coronary artery plaque extent and risk of major adverse cardiovascular events: the CONFIRM long-term registry. JACC Cardiovasc Imaging 9 (2016), 364–372.
11. [11] Patel, M.B., Bui, L.P., Kirkeeide, R.L., Gould, K.L., Imaging microvascular dysfunction and mechanisms for female–male differences in CAD. JACC Cardiovasc Imaging 9 (2016), 465–482.
12. [12] Sara, J.D., Widmer, R.J., Matsuzawa, Y., Lennon, R.J., Lerman, L.O., Lerman, A., Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv 8 (2015), 1445–1453.
13. [13] Taqueti, V.R., Everett, B.M., Murthy, V.L., Gaber, M., Foster, C.R., Hainer, J., et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation 131 (2015), 528–535.
14. [14] Kobayashi, Y., Fearon, W.F., Honda, Y., Tanaka, S., Pargaonkar, V., Fitzgerald, P.J., et al. Effect of sex differences on invasive measures of coronary microvascular dysfunction in patients with angina in the absence of obstructive coronary artery disease. JACC Cardiovasc Interv 8 (2015), 1433–1441.
15. [15] Lansky, A.J., Pietras, C., Coronary microvascular dysfunction: does sex matter?. JACC Cardiovasc Interv 8 (2015), 1442–1444.
16. [16] Shaw, L.J., Bairey Merz, C.N., Pepine, C.J., Reis, S.E., Bittner, V., Kelsey, S.F., et al. Insights from the NHLBI-sponsored Women׳s Ischemia Syndrome Evaluation (WISE) study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47:Suppl. 3 (2006), S4–S20.
17. [17] Jespersen, L., Hvelplund, A., Abildstrom, S.Z., Pedersen, F., Galatius, S., Madsen, J.K., et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33 (2012), 734–744.
18. [18] Pasupathy, S., Air, T., Dreyer, R.P., Tavella, R., Beltrame, J.F., Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 131 (2015), 861–870.
19. [19] Stone, G.W., Narula, J., The myth of the mild vulnerable plaques. JACC Cardiovasc Imaging 6 (2013), 1124–1126.
20. [20] Patel, M.R., Dai, D., Hernandez, A.F., Douglas, P.S., Messenger, J., Garratt, K.N., et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J, 167, 2014 846–852.e2.
21. [21] Robinson, J.G., Wallace, R., Limacher, M., Ren, H., Cochrane, B., Wassertheil-Smoller, S., et al. Cardiovascular risk in women with non-specific chest pain (from the Women׳s Health Initiative Hormone Trials). Am J Cardiol 102 (2008), 693–699.
22. [22] Hemal, K., Pagidipati, N.J., Coles, A., Dolor, R.J., Mark, D.B., Pellikka, P.A., et al. Sex differences in demographics, risk factors, presentation, and noninvasive testing in stable outpatients with suspected coronary artery disease: insights from the PROMISE trial. JACC Cardiovasc Imaging 9 (2016), 337–346.
23. [23] Ridker, P.M., Buring, J.E., Rifai, N., Cook, N.R., Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. J Am Med Assoc 297 (2007), 611–619.
24. [24] Fihn, S.D., Gardin, J.M., Abrams, J., Berra, K., Blankenship, J.C., Dallas, A.P., et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60 (2012), e44–e164.
25. [25] Baldassarre, L.A., Raman, S.V., Min, J.K., Mieres, J.H., Gulati, M., Wenger, N.K., et al. Noninvasive imaging to evaluate women with stable ischemic heart disease. JACC Cardiovasc Imaging 9 (2016), 421–435.
26. [26] Min, J.K., Dunning, A., Lin, F.Y., Achenbach, S., Al-Mallah, M., Budoff, M.J., et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 58 (2011), 849–860.
27. [27] Pagidipati, N.J., Hemal, K., Coles, A., Mark, D.B., Dolor, R.J., Pellikka, P.A., et al. Sex differences in functional and CT angiography testing in patients with suspected coronary artery disease. J Am Coll Cardiol 67 (2016), 2607–2616.
28. [28] Bittencourt, M.S., Hulten, E., Ghoshhajra, B., O׳Leary, D., Christman, M.P., Montana, P., et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging 7 (2014), 282–291.
29. [29] Johnson, N.P., Gould, K.L., Di Carli, M.F., Taqueti, V.R., Invasive FFR and noninvasive CFR in the evaluation of ischemia: what is the future?. J Am Coll Cardiol 67 (2016), 2772–2788.
30. [30] Mygind, N.D., Michelsen, M.M., Pena, A., Frestad, D., Dose, N., Aziz, A., et al. Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study. qJ Am Heart Assoc, 5, 2016, e003064.
31. [31] Reynolds, H.R., Srichai, M.B., Iqbal, S.N., Slater, J.N., Mancini, G.B., Feit, F., et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 124 (2011), 1414–1425.
32. [32] Lee, B.K., Lim, H.S., Fearon, W.F., Yong, A.S., Yamada, R., Tanaka, S., et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation 131 (2015), 1054–1060.
33. [33] Halcox, J.P., Schenke, W.H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M.A., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002), 653–658.
34. [34] Pepine, C.J., Anderson, R.D., Sharaf, B.L., Reis, S.E., Smith, K.M., Handberg, E.M., et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women׳s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 55 (2010), 2825–2832.
35. [35] Kang, S.J., Ahn, J.M., Han, S., Lee, J.Y., Kim, W.J., Park, D.W., et al. Sex differences in the visual-functional mismatch between coronary angiography or intravascular ultrasound versus fractional flow reserve. JACC Cardiovasc Interv 6 (2013), 562–568.
36. [36] Li, J., Rihal, C.S., Matsuo, Y., Elrashidi, M.Y., Flammer, A.J., Lee, M.S., et al. Sex-related differences in fractional flow reserve-guided treatment. Circ Cardiovasc Interv 6 (2013), 662–670.
37. [37] Kim, H.S., Tonino, P.A., De Bruyne, B., Yong, A.S., Tremmel, J.A., Pijls, N.H., et al. The impact of sex differences on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) substudy. JACC Cardiovasc Interv 5 (2012), 1037–1042.
38. [38] Chandrasekhar, J., Mehran, R., Sex-based differences in acute coronary syndromes: insights from invasive and noninvasive coronary technologies. JACC Cardiovasc Imaging 9 (2016), 451–464.
39. [39] Johnson, N.P., Toth, G.G., Lai, D., Zhu, H., Acar, G., Agostoni, P., et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 64 (2014), 1641–1654.
40. [40] Chow, B.J., Small, G., Yam, Y., Chen, L., McPherson, R., Achenbach, S., et al. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (Coronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry. Arterioscler Thromb Vasc Biol 35 (2015), 981–989.